Related Experiment Video
Updated: Mar 27, 2026
11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
16.8K
Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward
M D Stegall1, R E Morris2, R R Alloway3
1Departments of Surgery and Immunology, von Liebig Transplant Center, Mayo Clinic, Rochester, MN.
Summary
New immunosuppressive drug development for organ transplantation is stalling, threatening future patient care. This viewpoint identifies key barriers and proposes solutions for the transplant community to advance novel therapies.
Area of Science:
- Pharmacology
- Transplantation Medicine
- Drug Development
Background:
- The pipeline for novel immunosuppressive drugs has significantly slowed in recent years.
- This stagnation poses a serious challenge for the future of organ transplant recipients.
Purpose of the Study:
- To identify critical barriers hindering the development of new immunosuppressive medications.
- To propose actionable strategies for the transplant community to overcome these obstacles.
Main Methods:
- This is a viewpoint article, not based on original research.
- Analysis of current trends and challenges in immunosuppressive drug discovery.
Main Results:
- Several significant barriers impede the progress of new immunosuppressive drug development.
- Specific, actionable steps are proposed to address these challenges.
Conclusions:
- Urgent action is needed from the transplant community to revitalize immunosuppressive drug development.
- Overcoming identified barriers is crucial for ensuring improved therapies for future transplant recipients.
Related Concept Videos
01:40Cell-mediated Immune Responses
86.1K
Overview
86.1K
01:24Tissue Transplantation
1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
01:16Kidney Transplant III: Nursing Management
560
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
560
01:22Bone Marrow Sampling and Transplants
2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
01:28Kidney Transplant I: Introduction
686
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
686
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
663
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
663